TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 · Nucleic Acids Research · 5,470 citations
https://doi.org/10.1093/nar/gkaa407
J
Jingxin Fu
Broad Institute(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
189
Papers
13.4K
Citations
17
h-index
20
i10-index
Jingxin Fu is an academic researcher from Broad Institute. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Estrogen and related hormone effects & Immune Cell Function and Interaction. The author has an h-index of 17, co-authored 161 publications.
ORCID: 0000-0002-4028-3661Papers by this author
worksSignatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 · Nature Medicine · 5,444 citations
https://doi.org/10.1038/s41591-018-0136-1
Immune receptor repertoires in pediatric and adult acute myeloid leukemia
2019 · Genome Medicine · 49 citations
https://doi.org/10.1186/s13073-019-0681-3
Clonal tracing reveals diverse patterns of response to immune checkpoint blockade
2020 · Genome biology · 30 citations
https://doi.org/10.1186/s13059-020-02166-1
Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer
2025 · Nature Communications · 2 citations
https://doi.org/10.1038/s41467-025-66659-y
Dynamic single-cell systemic immune responses in immunotherapy-treated early-stage HR+ breast cancer patients
2025 · npj Breast Cancer · 1 citations
https://doi.org/10.1038/s41523-025-00776-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat